dactinomycin has been researched along with sch 23390 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, JU; Navakkode, S; Sacktor, TC; Sajikumar, S | 1 |
| Kiyokage, E; Kurokawa, K; Mizuno, K; Ohkuma, S; Shibasaki, M; Toida, K | 1 |
2 other study(ies) available for dactinomycin and sch 23390
| Article | Year |
|---|---|
Protein kinase Mzeta is essential for the induction and maintenance of dopamine-induced long-term potentiation in apical CA1 dendrites.
Topics: Animals; Benzazepines; Biophysics; CA1 Region, Hippocampal; Dactinomycin; Dendrites; Dopamine; Dopamine Antagonists; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Immunosuppressive Agents; In Vitro Techniques; Long-Term Potentiation; Male; Neurons; Patch-Clamp Techniques; Peptides; Protein Kinase C; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Sirolimus; Time Factors; Valine | 2010 |
Dopamine D1 receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons.
Topics: Animals; Benzazepines; Carbazoles; Cells, Cultured; Central Nervous System Stimulants; Cerebral Cortex; Dactinomycin; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Mesencephalon; Methamphetamine; Mice; Neurons; Pregnancy; Protein Synthesis Inhibitors; Pyrroles; Quinpirole; Receptors, Dopamine D1; Ryanodine Receptor Calcium Release Channel; Signal Transduction | 2011 |